NV
enVVeno Medical Corporation
NVNO · NASDAQ
$8.20 +2.37% (+$0.19)
1M -30.29%
Market Cap $5.57M
P/E Ratio -
Div. Yield -
ROE 62.28%
Bulios Fair Price
$10.39
26.7% upside
Current Price
$8.2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NVNO is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.27x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 11.19%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 69.39%
ROIC 79.12%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 11.70x
Debt/Equity 0.02x
Debt/Assets N/A
Stability
49 /100
Moderate Profitable years 0
Beta 1.07x
EPS volatility 44.21%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NVNO
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert A. Berman
Employees
33
Headquarters
Irvine
Upcoming events
30 OCT
Earnings
Upcoming earnings report